All of this news should serve as a reminder that theres a lot we still dont know about these drugs
Compliance News | November 11, 2025 The administration, together with pharmaceutical manufacturers Eli Lilly and Novo Nordisk, announced an agreement to lower prices and expand access to glucagon-like peptide-1 receptor agonists (GLP-1s) for weight loss for those in the Medicare Part D and Medicaid programs as well as direct-to-consumer (DTC) purchasing
Chloroform/methanol 96:4, direction 2
For guidance on water types, see bacteriostatic water vs sterile water
How to track progress and optimize GLP-1 results with habits and support Because progress with a GLP-1 builds over time, looking at overall trends can be more useful than watching daily changes
There is currently a lack of large-scale clinical trials specifically documenting the effects of high-dose glutathione supplementation on breastfeeding infants